Jackie M Ward
CIK 1086247 · last filed 2021-04-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
WLP price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
1390 ENCLAVE PARWAY
HOUSTON, TX 77077
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SANM | Director | 163,948 | $161.34 | $26.45M | -$4.18M | 46 | 2021-04-19 |
| SYY | Director | 161,483 | $82.16 | $13.27M | -$439.6K | 69 | 2018-09-28 |
| FLO | Director | 217,965 | $6.14 | $1.34M | $154.4K | 25 | 2014-01-03 |
| Elevance Health, Inc. (WLP) Delisted | Director | 23,914 | — | — | -$5.37M | 11 | 2012-05-18 |
| BANK OF AMERICA CORP /DE/ (IKR) Delisted | Director | 53,353 | — | — | $2.05M | 13 | 2009-05-01 |
| EFX | Director | 34,263 | $178.56 | $6.12M | $0 | 13 | 2008-07-02 |
Recent Filings · Page 7 of 18
177 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-06-07 | FLO | Grant (A) | — | $0 | EDGAR |
| 2012-05-18 | Elevance Health, Inc. (WLP) Delisted | Mixed | +2,946 | $0 | EDGAR |
| 2012-03-30 | SYY | Grant (A) | +1,214 | $36.2K | EDGAR |
| 2012-03-16 | SANM | Grant (A) | +18,999 | $220.0K | EDGAR |
| 2012-02-21 | Elevance Health, Inc. (WLP) Delisted | Mixed | +17,430 | -$4.2K | EDGAR |
| 2012-01-06 | FLO | Mixed | +6,735 | $126.3K | EDGAR |
| 2012-01-03 | SYY | Grant (A) | +1,226 | $36.2K | EDGAR |
| 2011-11-17 | SYY | Grant (A) | +5,787 | $0 | EDGAR |
| 2011-10-14 | SYY | Mixed | +122 | $7 | EDGAR |
| 2011-10-13 | SYY | Mixed | +302 | $3 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.